Literature DB >> 2675643

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.

M A Jenike1, L Baer, P Summergrad, J B Weilburg, A Holland, R Seymour.   

Abstract

Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2675643     DOI： 10.1176/ajp.146.10.1328

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  6 in total

Review 1.  Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.

Authors:  Winfried Rief; Yvonne Nestoriuc; Anna von Lilienfeld-Toal; Imis Dogan; Franziska Schreiber; Stefan G Hofmann; Arthur J Barsky; Jerry Avorn
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

2.  Single photon emission computerized tomography in obsessive compulsive disorder: a preliminary study.

Authors:  B L Adams; L B Warneke; A J McEwan; B A Fraser
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

3.  Obsessive-compulsive disorder and anorexia nervosa in a high school athlete: a case report.

Authors:  R L Gee; N Telew
Journal:  J Athl Train       Date:  1999-10       Impact factor: 2.860

4.  Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials.

Authors:  Chad T Wetterneck; Tannah E Little; Kimberly L Rinehart; Maritza E Cervantes; Emma Hyde; Monnica Williams
Journal:  J Obsessive Compuls Relat Disord       Date:  2012-01-08       Impact factor: 1.677

Review 5.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 6.  Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time.

Authors:  Georgios D Kotzalidis; Antonio Del Casale; Maurizio Simmaco; Lucia Pancheri; Roberto Brugnoli; Marco Paolini; Ida Gualtieri; Stefano Ferracuti; Valeria Savoja; Ilaria Cuomo; Lavinia De Chiara; Alessio Mosca; Gabriele Sani; Paolo Girardi; Maurizio Pompili; Chiara Rapinesi
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.